DO34 analog

• Product Name Alternative:

  PK-8165

• UNSPSC Description:

  DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100.

• Target Antigen:

  DAGL

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/DO34_analog.html

• Purity:

  98.42

• Solubility:

  DMSO : ≥ 105 mg/mL

• Smiles:

  O=C(N1C(CC2=CC=CC=C2)CN(C(OC(C)(C)C)=O)CC1)N3N=CC(C4=CC=C(OC(F)(F)F)C=C4)=N3

• Molecular Weight:

  531.53

• References & Citations:

  [1]WO 2017096315 A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  2098969-71-0